CD8A and neoplasm: Despite the identification of several correlates of response to ICB, including CD8 T cell infiltration of the tumor site, tumor mutational burden, and cytolytic T cell gene expression profiles (5–7), these metrics are not universal predictors of response across all tumor types and patient subsets.